Title:
|
BENEFIT-RISK ASSESSMENT OF MEDICINES
THE DEVELOPMENT AND APPLICATION OF A UNIVERSAL FRAMEWORK FOR DECISION-MAKING AND EFFECTIVE COMMUNICATION |
By: |
James Leong, Prof. Sam Salek, Prof. Stuart Walker |
Format: |
Hardback |
List price:
|
£44.99 |
Our price: |
£38.24 |
Discount: |
|
You save:
|
£6.75 |
|
|
|
|
ISBN 10: |
331915804X |
ISBN 13: |
9783319158044 |
Availability: |
Usually dispatched within 1-3 weeks.
Delivery
rates
|
Stock: |
Currently 0 available |
Publisher: |
SPRINGER INTERNATIONAL PUBLISHING AG |
Pub. date: |
22 April, 2015 |
Edition: |
2015 ed. |
Pages: |
317 |
Description: |
Benefit-Risk Assessment of Medicines |
Synopsis: |
This book proposes and investigates a universal framework, and accompanying documentation system, to facilitate and catalogue benefit-risk decisions; a valuable addition to the benefit-risk toolbox.Over the past decade, pharmaceutical companies and regulatory agencies have been reviewing the benefit-risk assessment of medicines with a view to developing a structured, systematic, standardized approach. Examining the evaluation of such an approach by several mature regulatory authorities ensures that the reader gains a unique insight into the ongoing debate in this area.The field of benefit-risk assessment continues to evolve at a rapid pace due to political and societal pressure, as is reflected in the recent FDA PUDFA agreement as well as in the EMA 2015 Roadmap. Rather than provide a comprehensive snap-shot of this constantly changing environment, this book evaluates selected current approaches to benefit-risk assessment. The strengths and weaknesses of publicly available documents in communicating benefit-risk decisions to stakeholders are reviewed and these evaluations are used to inform development of a prospective framework that could be used to harmonise procedures globally. |
Illustrations: |
138 Illustrations, color; 25 Illustrations, black and white; XIII, 317 p. |
Publication: |
Switzerland |
Imprint: |
Adis |
Returns: |
Returnable |